[Xenotransplantation: a program for development].
Paradis
K
K
Novartis Pharma, Rueil Malmaison, France.
D000208:Acute Disease; D000818:Animals; D006084:Graft Rejection / Q000517:prevention & control*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D012192:Retroviridae Infections / Q000517:prevention & control / Q000635:transmission / Q000662:veterinary; D012449:Safety; D014183:Transplantation, Heterologous / Q000276:immunology* / Q000379:methods / Q000592:standards*; D015047:Zoonoses / Q000635:transmission
D007166:Immunosuppressive Agents
Xénotransplantation: un programme de développement.